García Patricia J, Bayer Angela, Cárcamo César P
Epidemiology, STD, and HIV Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Honorio Delgado 430. Ingenieria, Lima 31, Peru,
Curr HIV/AIDS Rep. 2014 Jun;11(2):146-57. doi: 10.1007/s11904-014-0204-1.
Latin America and the Caribbean (LAC) is a region with similarities and important disparities. In recent years LAC has witnessed achievements, with HIV prevalence rates relatively stable for LA and decreasing for the Caribbean. However average values hide differences. General population HIV prevalence in LAC is 0.4 % on average. In the Caribbean there are fewer new HIV infections but HIV prevalence among adults exceeds 1 % in several countries. It is estimated that 31 % of adults living with HIV in LA and 52 % of adults in the Caribbean are women. Unprotected sex is the main route of HIV transmission in LAC. Men who have sex with men and transgender women are the populations with the highest prevalence (10.6 % and 17.7 % respectively); however other key populations such as female sex workers (4.9 %), drug users (range 1 %-49.7 % for intravenous drug users), prisoners and indigenous populations are also important. LAC has the highest anti-retroviral treatment coverage of any low- and middle-income region in the world, but women and children are less likely than men to receive treatment. There is an important pending agenda to address the gaps in information, prevention, and care for HIV in LAC.
拉丁美洲和加勒比地区(LAC)是一个存在相似性但也有重大差异的地区。近年来,LAC取得了一些成就,拉丁美洲的艾滋病毒流行率相对稳定,加勒比地区的流行率则在下降。然而,平均数值掩盖了差异。LAC地区普通人群的艾滋病毒平均流行率为0.4%。在加勒比地区,新感染艾滋病毒的人数较少,但在一些国家,成年人中的艾滋病毒流行率超过1%。据估计,拉丁美洲31%的艾滋病毒感染成年人为女性,加勒比地区这一比例为52%。无保护性行为是LAC地区艾滋病毒传播的主要途径。男男性行为者和跨性别女性是患病率最高的人群(分别为10.6%和17.7%);然而,其他关键人群,如女性性工作者(4.9%)、吸毒者(静脉吸毒者的比例在1%至49.7%之间)、囚犯和土著居民也很重要。LAC地区在世界所有低收入和中等收入地区中抗逆转录病毒治疗覆盖率最高,但女性和儿童接受治疗的可能性低于男性。解决LAC地区在艾滋病毒信息、预防和护理方面的差距是一项重要的待办议程。
Curr HIV/AIDS Rep. 2014-6
Int J Public Health. 2015-11
Curr Opin HIV AIDS. 2014-3
Curr HIV/AIDS Rep. 2014-6
Curr HIV/AIDS Rep. 2021-2
J Int AIDS Soc. 2020-8
Curr Opin HIV AIDS. 2014-3
PLoS One. 2013-12-9
Rev Peru Med Exp Salud Publica. 2013-7